Document Detail


Reversal of locked-in syndrome with anticoagulation, induced hypertension, and intravenous t-PA.
MedLine Citation:
PMID:  16159079     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Widespread use of intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke is limited by multiple contraindications to its use. CASE REPORT: This article describes a patient with stuttering symptoms of pontine ischemia caused by vertebrobasilar dissection who suddenly deteriorated into a locked-in state 32 hours after symptom onset. The quadriparesis was successfully reversed within 3 hours of onset with the combination of pharmacologically induced hypertension, anticoagulation, and intravenous t-PA. DISCUSSION: Even in the face of numerous contraindications (including hypertension, anticoagulation, and treatment beyond 3 hours of symptom onset), intravenous t-PA can be used successfully in carefully selected cases.
Authors:
Nazli Janjua; Katja E Wartenberg; Philip M Meyers; Stephan A Mayer
Related Documents :
12508189 - Coronary angiography in the fully anticoagulated patient: the transradial route is succ...
16195779 - Repeated remissions of cushing's disease due to recurrent infarctions of an acth-produc...
21431879 - Mortality due to myocardial infarction in the bavarian population during world cup socc...
17123649 - Large recesses associated with left ventricular noncompaction: an unusual presentation ...
16188499 - Ventricular remodeling in loeffler endocarditis: implications for therapeutic decision ...
17574129 - 3d and 2d delayed-enhancement magnetic resonance imaging for detection of myocardial in...
15459449 - Developmental changes in dopamine modulation of the heart in the isopod crustacean ligi...
9115079 - Management of unstable angina: the role of noninvasive risk stratification.
23916739 - Atrioventricular heart block and syncope coincident with diagnosis of systemic lupus er...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Neurocritical care     Volume:  2     ISSN:  1541-6933     ISO Abbreviation:  Neurocrit Care     Publication Date:  2005  
Date Detail:
Created Date:  2005-09-14     Completed Date:  2005-11-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101156086     Medline TA:  Neurocrit Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  296-9     Citation Subset:  IM    
Affiliation:
The Neurological Intensive Care Unit, Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA. janjuana@umdnj.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anticoagulants / therapeutic use
Drug Administration Schedule
Humans
Infusions, Intravenous
Male
Plasminogen Activators / administration & dosage*
Quadriplegia / drug therapy*,  etiology
Tissue Plasminogen Activator / administration & dosage*
Vasoconstrictor Agents / therapeutic use
Vertebral Artery Dissection / complications
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Vasoconstrictor Agents; EC 3.4.21.-/Plasminogen Activators; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Contraceptive-related cerebral venous thrombosis with profuse vaginal bleed.
Next Document:  Cerebral gumma mimicking glioblastoma multiforme.